Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Classement en actions #16436
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Prix de l'action
$4.64
Dernière synchronisation: 2022-09-12
Capitalisation boursière
$293.43M
Changement (1 jour)
0.87%
Changement (1 an)
0.00%
Pays
US
Échange Adagio Therapeutics, Inc. (ADGI)

Catégorie

Historique du prix de l'action pour Adagio Therapeutics, Inc. (ADGI)
Prix de clôture le plus élevé : $4.63 le 2022-09-01

Prix de clôture le plus bas : $27.68 le 2021-08-01
Historique du prix de l'action de Adagio Therapeutics, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2022 -78.16%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.14 -10.08%
AU
$748.60 6.90%
CH